OTC · Drug Manufacturers - Specialty & Generic

Cryomass Technologies Inc. (CRYM) Stock

$0.00 OTC: CRYM Healthcare

Cryomass Technologies Inc., established in 2011 and based in Denver, Colorado, specializes in the development, distribution, and commercialization of cryo-mechanical systems. These systems are specifically engineered for processing freshly harvested hemp, cannabis, and other premium botanical materials.

Valuation

MetricValue
Price$0.00
Market Cap$47432
P/E Ratio0.00
P/B Ratio-0.01
P/S Ratio1.26
EPS (TTM)$-0.03
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE216.67%
ROA-262.09%
ROCE708.66%
Gross Margin100.00%
Operating Margin-17317.18%
Net Margin0.00%
Debt/Equity-0.67
Current Ratio0.04

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$1.0M$0$0$0
Operating Profit$-3.0M$-7.0M$-8.0M$-10.0M$-11.0M
Net Profit$-3.0M$-12.0M$-10.0M$-10.0M$-13.0M
EPS$-0.03$-0.12$-0.06$-0.05$-0.06
Op Margin-18265.0%-836.3%——-79560.2%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$16.0M$8.0M$16.0M$8.0M$1.0M
Total Liabilities$2.0M$4.0M$2.0M$3.0M$7.0M
Cash$3.0M$0$6.0M$2.0M$0
Borrowings$2.0M$0$0$2.0M$4.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-2.0M$-4.0M$-6.0M$-5.0M$-4.0M
Investing Cash Flow$-2.0M$-1.0M$-3.0M$-1.0M$0
Financing Cash Flow$0$0$-1.0M$0$0
Net Cash Flow$3.0M$-3.0M$5.0M$-4.0M$-2.0M
Free Cash Flow$-2.0M$-4.0M$-6.0M$-5.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.37
FCF Yield-8178.48%
Quick Ratio0.06
Interest Coverage-27.72
Return 1Y-60.00%
Return 3Y-99.85%
Return 5Y—

Ownership

Insiders Held15.72%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Cryomass Technologies Inc.

Cryomass Technologies Inc., established in 2011 and based in Denver, Colorado, specializes in the development, distribution, and commercialization of cryo-mechanical systems. These systems are specifically engineered for processing freshly harvested hemp, cannabis, and other premium botanical materials. The company rebranded to its current name in August 2021, having previously operated as Andina Gold Corp.

Cryomass Technologies Inc. (CRYM) stock trades at $0.00 with a market capitalization of $47432. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -0.01, price-to-sales of 1.26. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Cryomass Technologies Inc. generates a return on equity (ROE) of 216.67% — well above the market average, a sign of a high-quality business, return on capital employed of 708.66%, an operating margin of -17317.18%, a net profit margin of 0.00%.

Official website: cryomass.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides